Treatments to save synapses

THE global review of dementia drugs led by the University of Nevada in the US revealed amyloid drugs now make up only a third of the 138 drugs being trialled.

- 

Some drugs are being developed to protect the synapses - connections between brain cells which become damaged in Alzheimer’s patients. Others replace the chemical messengers that send signals between brain cell